ID   BG02
AC   CVCL_9729
SY   BG02ES; hESBGN-02; HESBGN-02; BGN-02; VIACe002-A; BresaGen 02
DR   EFO; EFO_0002778
DR   BioSample; SAMN03471900
DR   ENCODE; ENCBS274AAA
DR   ENCODE; ENCBS275AAA
DR   ENCODE; ENCBS276AAA
DR   ENCODE; ENCBS277AAA
DR   ENCODE; ENCBS278AAA
DR   ENCODE; ENCBS279AAA
DR   ENCODE; ENCBS280AAA
DR   ENCODE; ENCBS281AAA
DR   GEO; GSM472944
DR   GEO; GSM500933
DR   GEO; GSM500934
DR   GEO; GSM856720
DR   GEO; GSM862731
DR   GEO; GSM923453
DR   hPSCreg; VIACe002-A
DR   ISCR; 64
DR   SKIP; SKIP001939
DR   WiCell; bg02
DR   Wikidata; Q54796222
RX   PubMed=12968106;
RX   PubMed=15153607;
RX   PubMed=15684826;
RX   PubMed=16919167;
RX   PubMed=17572666;
RX   PubMed=23117585;
WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/BG02ES_and_H9ES_Myers_protocols.pdf
WW   http://stemcells.nih.gov/staticresources/research/protocols/BresaGen_hESC_manual_2.1.pdf
WW   https://stemcelldb.nih.gov/cellLineDetails.do?id=11
CC   Part of: ENCODE project common cell types; tier 3.
CC   From: ViaCyte, Inc. (originally from BresaGen); San Diego; USA.
CC   HLA typing: A*24,68; B*35:11,35; C*03,04; DQB1*03,06:01; DRB1*15,16:02; DRB5*01 (PubMed=16919167).
CC   HLA typing: A*24:02,68:01; B*35:03:35:11; C*03:04,04:01; DQB1*03:01,06:01; DRB1*15:02,16:02 (PubMed=15684826).
CC   Omics: Transcriptome analysis by massively parallel signature sequencing (MPSS).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=15684826; PubMed=16919167; WiCell
ST   Amelogenin: X,Y
ST   CSF1PO: 8,10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 14,16
ST   D19S433: 13,14.2
ST   D21S11: 27,30
ST   D2S1338: 17,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 12,14
ST   D8S1179: 13,14
ST   FGA: 20,25
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 21
//
RX   PubMed=12968106; DOI=10.1634/stemcells.21-5-521;
RA   Mitalipova M., Calhoun J., Shin S., Wininger D., Schulz T., Noggle S.A.,
RA   Venable A., Lyons I.G., Robins A., Stice S.L.;
RT   "Human embryonic stem cell lines derived from discarded embryos.";
RL   Stem Cells 21:521-526(2003).
//
RX   PubMed=15153607; DOI=10.1634/stemcells.22-3-292;
RA   Zeng X.-M., Miura T., Luo Y.-Q., Bhattacharya B., Condie B., Chen J.,
RA   Ginis I., Lyons I.G., Mejido J., Puri R.K., Rao M.S., Freed W.J.;
RT   "Properties of pluripotent human embryonic stem cells BG01 and BG02.";
RL   Stem Cells 22:292-312(2004).
//
RX   PubMed=15684826; DOI=10.1089/scd.2004.13.585;
RA   Brimble S.N., Zeng X.-M., Weiler D.A., Luo Y.-Q., Liu Y., Lyons I.G.,
RA   Freed W.J., Robins A.J., Rao M.S., Schulz T.C.;
RT   "Karyotypic stability, genotyping, differentiation, feeder-free
RT   maintenance, and gene expression sampling in three human embryonic
RT   stem cell lines derived prior to August 9, 2001.";
RL   Stem Cells Dev. 13:585-597(2004).
//
RX   PubMed=16919167; DOI=10.1186/1741-7007-4-28;
RA   Josephson R., Sykes G.R., Liu Y., Ording C.J., Xu W.-N., Zeng X.-M.,
RA   Shin S., Loring J.F., Maitra A., Rao M.S., Auerbach J.M.;
RT   "A molecular scheme for improved characterization of human embryonic
RT   stem cell lines.";
RL   BMC Biol. 4:28.1-28.13(2006).
//
RX   PubMed=17572666; DOI=10.1038/nbt1318;
RA   Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W.,
RA   Beighton G., Bello P.A., Benvenisty N., Berry L.S., Bevan S., Blum B.,
RA   Brooking J., Chen K.G., Choo A.B.-H., Churchill G.A., Corbel M.,
RA   Damjanov I., Draper J.S., Dvorak P., Emanuelsson K., Fleck R.A.,
RA   Ford A., Gertow K., Gertsenstein M., Gokhale P.J., Hamilton R.S.,
RA   Hampl A., Healy L.E., Hovatta O., Hyllner J., Imreh M.P.,
RA   Itskovitz-Eldor J., Jackson J., Johnson J.L., Jones M., Kee K.,
RA   King B.L., Knowles B.B., Lako M., Lebrin F., Mallon B.S., Manning D.,
RA   Mayshar Y., McKay R.D.G., Michalska A.E., Mikkola M., Mileikovsky M.,
RA   Minger S.L., Moore H.D., Mummery C.L., Nagy A., Nakatsuji N.,
RA   O'Brien C.M., Oh S.K.-W., Olsson C., Otonkoski T., Park K.-Y.,
RA   Passier R., Patel H., Patel M.J., Pedersen R., Pera M.F.,
RA   Piekarczyk M.S., Reijo Pera R.A., Reubinoff B.E., Robins A.J.,
RA   Rossant J., Rugg-Gunn P., Schulz T.C., Semb H., Sherrer E.S., Siemen H.,
RA   Stacey G.N., Stojkovic M., Suemori H., Szatkiewicz J., Turetsky T.T.,
RA   Tuuri T., van den Brink S., Vintersten K., Vuoristo S.,
RA   Ward-van Oostwaard D., Weaver T.A., Young L.A., Zhang W.-D.;
RT   "Characterization of human embryonic stem cell lines by the
RT   International Stem Cell Initiative.";
RL   Nat. Biotechnol. 25:803-816(2007).
//
RX   PubMed=23117585; DOI=10.1016/j.scr.2012.09.002;
RA   Mallon B.S., Chenoweth J.G., Johnson K.R., Hamilton R.S., Tesar P.J.,
RA   Yavatkar A.S., Tyson L.J., Park K., Chen K.G., Fann Y.C., McKay R.D.G.;
RT   "StemCellDB: the human pluripotent stem cell database at the National
RT   Institutes of Health.";
RL   Stem Cell Res. 10:57-66(2013).
//